Seres Therapeutics Inc (MCRB) Stock Price, Quote & News

Company Profile

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize gastrointestinal pathogens, enhance epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. Its other pipeline pr...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 945 9626

Website: www.serestherapeutics.com

Address:

101 Cambridgepark Drive, Cambridge, United States

BioCrazy1 Oct. 4 at 6:20 PM

$MCRB

0 · Reply

TotalChamp Oct. 4 at 2:43 PM

$MCRB in the event a BO is declared, as shareholders what actions do we need to take. Clarity is appreciated! I haven’t invested long and have yet to be involved in an acquisition as a shareholder

1 · Reply

Whitenoise27 Oct. 4 at 10:38 AM

$MCRB if (when) B/O this could easily hit high 60s70s fast Imo

1 · Reply

LionNoRichy Oct. 4 at 7:48 AM

$MCRB BO Monday

1 · Reply

LiquidThetaLEAPS Oct. 4 at 2:59 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MCRB Current Share Price: $20.59 Contracts: $MCRB January 15, 2027 $20 Calls Scale in: $5.17- $6.33 Scale out: $8.05-$10.35 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Whiskeyunderthebed Oct. 3 at 7:50 PM

$MCRB the shares are locked up on this one-nobody is selling this.

0 · Reply

TotalChamp Oct. 3 at 7:25 PM

$MCRB several days in a row we’ve had a nice little chunk (a buy) at the end of the day. Will we see the same today? Although I’ll argue against my own point, it really doesn’t matter. I’m not looking at SP because I’m expecting an acquisition.

0 · Reply

BioCrazy1 Oct. 3 at 7:11 PM

$MCRB Dark pool action picking up with that trade.

1 · Reply

IBCandBIOTECH Oct. 3 at 7:08 PM

$MCRB Are you a prophet? 😂

1 · Reply

BioCrazy1 Oct. 3 at 7:07 PM

$MCRB Damn!, nice green candle !

0 · Reply

Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway

Sep 22, 2025, 12:10 PM EDT - 12 days ago

More companies adopt co-CEO structure

IREN KKR LEN NFLX ORCL SBET

Aug 27, 2025, 7:00 AM EDT - 5 weeks ago

Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Aug 6, 2025, 9:47 PM EDT - 2 months ago

Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 7:00 AM EDT - 2 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

SANA

Jul 29, 2025, 2:09 PM EDT - 2 months ago

Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough

Jul 22, 2025, 7:01 AM EDT - 2 months ago

Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025

Jul 22, 2025, 7:00 AM EDT - 2 months ago

Seres Therapeutics Announces Leadership Transition

May 27, 2025, 7:00 AM EDT - 4 months ago

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

May 7, 2025, 2:18 PM EDT - 5 months ago

Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:00 AM EDT - 5 months ago

Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates

Apr 29, 2025, 7:00 AM EDT - 5 months ago

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

Apr 23, 2025, 7:00 AM EDT - 5 months ago

Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025

Mar 13, 2025, 11:04 AM EDT - 7 months ago

Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 7:00 AM EDT - 7 months ago

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 4, 2025, 7:00 AM EST - 7 months ago

Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

Mar 3, 2025, 7:00 AM EST - 7 months ago

Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach

Jan 16, 2025, 7:00 AM EST - 9 months ago

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

Jan 9, 2025, 7:00 AM EST - 9 months ago

Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates

Dec 16, 2024, 7:00 AM EST - 10 months ago

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference

Nov 22, 2024, 7:00 AM EST - 11 months ago

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Nov 13, 2024, 10:28 AM EST - 11 months ago

Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 7:00 AM EST - 11 months ago

Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024

Sep 30, 2024, 5:15 PM EDT - 1 year ago

Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A

Sep 27, 2024, 3:26 PM EDT - 1 year ago

Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé

Sep 26, 2024, 4:01 PM EDT - 1 year ago

Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30

Sep 23, 2024, 12:14 AM EDT - 1 year ago

Seres Therapeutics' Strategic Sale Of Vowst Warrants A Rating Upgrade

Sep 13, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference

Sep 12, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

Aug 13, 2024, 3:35 PM EDT - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024

Aug 6, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science

Jun 7, 2024, 4:00 PM EDT - 1 year ago

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 6, 2024, 7:00 AM EDT - 1 year ago

Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023

Jun 6, 2024, 6:30 AM EDT - 1 year ago

Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science

May 11, 2024, 5:34 PM EDT - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript

May 8, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 6, 2024, 9:30 AM EDT - 1 year ago

Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024

Apr 9, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT

Apr 2, 2024, 2:10 AM EDT - 1 year ago

VKTX, JANX and these biotech stocks are surging in 2024

ARQT JANX VKTX AMLX RAPT RVNC

Mar 5, 2024, 3:33 PM EST - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

Feb 28, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024

Feb 27, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference

Feb 26, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz

Jan 9, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155

Jan 4, 2024, 4:00 PM EST - 1 year ago

Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 7, 2023, 7:46 PM EST - 1 year ago

Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023

Nov 28, 2023, 9:18 AM EST - 2 years ago

Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET

BioCrazy1 Oct. 4 at 6:20 PM

$MCRB

0 · Reply

TotalChamp Oct. 4 at 2:43 PM

$MCRB in the event a BO is declared, as shareholders what actions do we need to take. Clarity is appreciated! I haven’t invested long and have yet to be involved in an acquisition as a shareholder

1 · Reply

Whitenoise27 Oct. 4 at 10:38 AM

$MCRB if (when) B/O this could easily hit high 60s70s fast Imo

1 · Reply

LionNoRichy Oct. 4 at 7:48 AM

$MCRB BO Monday

1 · Reply

LiquidThetaLEAPS Oct. 4 at 2:59 AM

0 · Reply

Whiskeyunderthebed Oct. 3 at 7:50 PM

$MCRB the shares are locked up on this one-nobody is selling this.

0 · Reply

TotalChamp Oct. 3 at 7:25 PM

0 · Reply

BioCrazy1 Oct. 3 at 7:11 PM

$MCRB Dark pool action picking up with that trade.

1 · Reply

IBCandBIOTECH Oct. 3 at 7:08 PM

$MCRB Are you a prophet? 😂

1 · Reply

BioCrazy1 Oct. 3 at 7:07 PM

$MCRB Damn!, nice green candle !

0 · Reply

Radu10 Oct. 3 at 6:56 PM

$MCRB 🇺🇲

0 · Reply

Thepark88 Oct. 3 at 6:56 PM

$MCRB casual half million $ buy

1 · Reply

Thepark88 Oct. 3 at 6:55 PM

$MCRB orchestrated - look at the size of that candle

0 · Reply

jow18 Oct. 3 at 6:38 PM

$MCRB

0 · Reply

Fairvalue10 Oct. 3 at 6:35 PM

$MCRB No volume ….

0 · Reply

BioCrazy1 Oct. 3 at 6:09 PM

$MCRB Above normal volume on a Friday. The market maker was hoping for sellers to the upside at 21.90. Now he's hoping for sellers to the downside at 19.30. He is looking for shares ! Buyout Monday, here we come! At least that's what I'm going to tell myself.

1 · Reply

I_am_Sparta Oct. 3 at 6:01 PM

$MCRB mc rib to single Digits 💩💩💩🤟🏻

1 · Reply

Tritsortreat2020 Oct. 3 at 5:58 PM

$MCRB ignore gthx. he clearly has a ”motive” here. also, i like iova but im gonna wait to buy ;)

0 · Reply

gthx Oct. 3 at 5:19 PM

$MCRB good luck everyone. I’m out. Made good money but the cost of waiting is too much. So I think I’m out for good. I moved to RR. Plan to add to my IOVA position at the start of November. May you all make a ton on the buyout!

2 · Reply

BioCrazy1 Oct. 3 at 5:02 PM

$MCRB Somebody is dumping shares.

3 · Reply

Radu10 Oct. 3 at 4:40 PM

$MCRB 🇺🇲.

0 · Reply

Thepark88 Oct. 3 at 4:32 PM

$MCRB stop loss road, back up to $20.50, announce the deal exactly as it was reported by Lukas 😂 take that right now

1 · Reply

Market Cap	184.20M
Revenue (ttm)	0.00
Net Income (ttm)	140,000.00
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	264,900
Avg Vol	183,164
Day's Range	N/A - N/A
Shares Out	8.76M
Stochastic %K	77%
Beta	0.19
Analysts	Sell
Price Target	$16.00